Are feelings of responsibility to limit the sexual transmission of HIV associated with safer sex among HIV-positive injection drug users?

Journal of Acquired Immune Deficiency Syndromes

Volumn 46, Issue SUPPL. 2, 2007, Pages

  Latka, Mary H ^a,g   Mizuno, Yuko ^b   Wu, Yingfeng ^a   Tobin, Karin E ^c   Metsch, Lisa R ^d   Frye, Victoria ^a   Gómez, Cynthia A ^e   Arnsten, Julia H ^f  

^a NEW YORK ACADEMY OF MEDICINE   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^d UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^g AURUM INSTITUTE   (South Africa)

Author keywords

HIV; Injection drug user; Responsibility; Seropositive; Sexual risk behavior

Indexed keywords

ARTICLE; CRONBACH ALPHA COEFFICIENT; DRUG USE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SAFE SEX; SELF CONCEPT; SEXUAL TRANSMISSION; VIRUS TRANSMISSION;

ADULT; DATA COLLECTION; FEMALE; HIV INFECTIONS; HUMANS; MALE; RISK FACTORS; SAFE SEX; SELF DISCLOSURE; SOCIAL RESPONSIBILITY; SUBSTANCE ABUSE, INTRAVENOUS; UNITED STATES;

EID: 37349048940     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAI.0b013e31815767b3     Document Type: Article

References (28)

1. Murrill CS, Weeks H, Castrucci BC, et al. Age-specific seroprevalence of HIV, hepatitis B virus, and hepatitis C virus infection among injection drug users admitted to drug treatment in 6 US cities. Am J Public Health. 2002;92:385-387.
2. Semaan S, Kotranski L, Collier K, et al. Temporal trends in HIV risk behaviors of out-of-treatment injection drug users and injection drug users who smoke crack. J Acquir Immune Defic Syndr Hum Retrovirol. 1998;19:274-281.
3. Wiebel WW, Jimenez A, Johnson W, et al. Risk behavior and HIV seroincidence among out-of-treatment injection drug users: a 4-year prospective study. J Acquir Immune Defic Syndr Hum Retrovirol. 1996;12:282-289.
4. Kral AH, Bluthenthal RN, Lorvick J, et al. Sexual transmission of HIV-1 among injection drug users in San Francisco, USA: risk-factor analysis. Lancet. 2001;357:1397-1401.
5. Strathdee SA, Sherman SG. The role of sexual transmission of HIV infection among injection and non-injection drug users. J Urban Health. 2003;80:iii7-iii14.
6. Centers for Disease Control and Prevention. Advancing HIV prevention: new strategies for a changing epidemic - United States, 2003. MMWR Morb Mortal Wkly Rep. 2003;52:329-332.
7. Centers for Disease Control and Prevention. Incorporating HIV prevention into the medical care of persons living with HIV. Recommendations of CDC, the Health Resources and Services Administration, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. MMWR Recomm Rep. 2003;52:1-24.
8. Janssen RS, Valdiserri RO. HIV prevention in the United States: increasing emphasis on working with those living with HIV. J Acquir Immune Defic Syndr. 2004;37(Suppl 2):S119-S121.
9. Marks G, Burris S, Peterman TA. Reducing sexual transmission of HIV from those who know they are infected: the need for personal and collective responsibility. AIDS. 1999;13:297-306.
10. Wolitski RJ, Bailey CJ, O'Leary A, et al. Seropositive Urban Men's Study (SUMS). Self-perceived responsibility of HIV-seropositivemen who have sex with men for preventing HIV transmission. AIDS Behav. 2003;7:363-372.
11. Sheon N, Crosby MG. Ambivalent tales of HIV disclosure in San Francisco. Soc Sci Med. 2004;58:2105-2118.
12. O'Leary A, Hoff CC, Purcell DW, et al. What happened in the SUMIT trial? Mediation and behavior change. AIDS. 2005;19(Suppl):S111-S121.
13. Wolitski RJ, Parsons JT, Gomez CA, for the SUMS and SUMIT Study Teams. Prevention with HIV-seropositive men who have sex with men: lessons from the Seropositive Urban Men's Study (SUMS) and the Seropositive Urban Men's Intervention Trial (SUMIT). J Acquir Immune Defic Syndr. 2004;37(Suppl):S101-S109.
14. Wolitski RJ, Flores SA, O'Leary A, et al. Beliefs about personal and partner responsibility among HIV-seropositive men who have sex with men: measurement and association with transmission risk behavior. AIDS Behav. 2007;11:676-686.
15. Knight KR, Purcell D, Dawson-Rose C, et al. Sexual risk taking among HIV-positive injection drug users: contexts, characteristics, and implications for prevention. AIDS Educ Prev. 2005;17(Suppl A):76-88.
16. Parsons JT, VanOra J, Missildine W, et al. Positive and negative consequences of HIV disclosure among seropositive injection drug users. AIDS Educ Prev. 2004;16:459-475.
17. Purcell DW, Metsch LR, Latka M, et al, for the INSPIRE Study Group. Interventions for seropositive injectors - research and evaluation: an integrated behavioral intervention with HIV-positive injection drug users to address medical care, adherence, and risk reduction. J Acquir Immune Defic Syndr. 2004;37(Suppl):S110-S118.
18. DeVellis RF. Scale Development Theory and Applications. Newbury Park, CA: Sage Publications; 1991.
19. Padian NS, Shiboski SC, Glass SO, et al. Heterosexual transmission of human immunodeficiency virus (HIV) in northern California: results from a ten-year study. Am J Epidemiol. 1997;146:350-357.
20. Pinkerton SD, Abramson PR, Kalichman SC, et al. Secondary HIV transmission rates in a mixed-gender sample. Int J STD AIDS. 2000;11:38-44.
21. Derogatis LR, Spencer PM. Brief Symptoms Inventory. Baltimore, MD: John Wiley & Sons; 1982.
22. Rogers ES, Chamberlin J, Ellison ML, et al. A consumer-constructed scale to measure empowerment among users of mental health services. Psychiatr Serv. 1997;48:1042-1047.
23. Barrera MA. A method for assessing social support networks in community survey research. Connections. 1980;3:8-13.
24. de Vincenzi I. A longitudinal study of human immunodeficiency virus transmission by heterosexual partners. European Study Group on Heterosexual Transmission of HIV. N Engl J Med. 1994;331:341-346.
25. Chan DJ. Factors affecting sexual transmission of HIV-1: current evidence and implications for prevention. Curr HIV Res. 2005;3:223-241.
26. Weiss SH, Weston CB, Quirinale J. Safe sex? Misconceptions, gender differences and barriers among injection drug users: a focus group approach. AIDS Educ Prev. 1993;5:279-293.
27. Samuels JF, Vlahov D, Anthony JC, et al. Measurement of HIV risk behaviors among intravenous drug users. Br J Addict. 1992;87:417-428.
28. Macalino GE, Celentano DD, Latkin C, et al. Risk behaviors by audio computer-assisted self-interviews among HIV-seropositive and HIV-seronegative injection drug users. AIDS Educ Prev. 2002;14:367-378.